{"task_id": "4e32723417d97ca2", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 170/464)", "text": ")\nINVESTIGATIONS (CONT\u2019D)\n158\nDeep Vein Thrombosis\n\n--- Page 180 ---\nPROTEIN S AND PROTEIN C DEFICIENCY WHILE\nANTICOAGULATED\nwhen\nanticoagulated,\nusually levels decrease by similar proportion. If sig\nnificant decrease of one compared to the other,\nmay suggest a deficiency\nMANAGEMENT\nANTICOAGULATION\nheparin\n(unfractionated\nheparin 5000U IV bolus, then 1000U/h, and adjust to\n1.5 2.5\u0003 normal PTT) or LMWH (enoxaparin 1 mg/kg\nSC BID or 1.5 mg/kg SC daily). For long term antic\noagulation, continue LMWH in cancer patients or\nstart warfarin 5 mg PO daily within 72 hours and\ncontinue heparin/LMWH until INR is between 2 and 3\nfor two consecutive days\nIVC FILTER\nif anticoagulation contraindicated\nTHROMBOLYSIS\nmay have a role in hemodynami\ncally unstable pulmonary embolism or massive iliofe\nmoral thrombosis\nTREATMENT ISSUES\nANTICOAGULATION DURATION\n\u0002\nAT LEAST 6 MONTHS\nfirst DVT with reversible or\ntime limited risk factor removed (i.e. if DVT in\nsecond term of pregnancy, stop therapy 3 months\npost partum)\n\u0002\nAT LEAST 1 YEAR\nfirst DVT and idiopathic\nTREATMENT ISSUES (CONT\u2019D)\n\u0002\nLIKELY\nLIFELONG\nrecurrent idiopathic DVT or\ncontinuing major risk factor (malignancy, antith\nrombin III deficiency, homozygous factor V Leiden,\nhomozygous prothrombin G20210A, heterozygous\nfactor V Leiden plus prothrombin G20210A)\nCONTRAINDICATIONS TO ANTICOAGULATION\nTHERAPY\n\u0002\nABSOLUTE\nneurosurgery, ocular surgery, or intra\ncranial bleeding within the past 10 days, active\nbleeding, severe bleeding diathesis, or platelet\n< 20\u0003103/mL\n\u0002\nRELATIVE\nmild moderate bleeding diathesis or\nthrombocytopenia (20 100\u0003103/mL), brain metas\ntases from melanoma, renal cell carcinoma, chor\niocarcinoma and thyroid cancers, recent major\ntrauma, major abdominal surgery < 2 days, GI or\nGU bleeding\n< 2 weeks, endocarditis, severe\nhypertension (>200/120 mmHg)\nSPECIFIC ENTITIES\nSUPERFICIAL THROMBOPHLEBITIS\ncharacterized\nby painful, erythematous, palpable cord along a super\nficial vein usually in the lower extremity, can be asso\nciated with hypercoagulable states. Extension to deep\nvein system rarely occurs through perforating veins\nand is most likely when the proximal greater saphe\nnous vein or saphenous femoral junction is involved\nNotes\nDIAGNOSTIC ISSUES (CONT\u2019D)\nNotes\n159", "text_length": 2245, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 170/464)", "type": "chunk", "chunk_index": 169, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.479529", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.480465", "status": "complete", "chunks_added": 2}